Clinical trial
A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
NCT01931644 is registered in ClinicalTrials.gov with Sanguine Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
- Lead sponsor
- Sanguine Biosciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- April 30, 2024
- Enrollment
- 17,667 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
add/adhd, all diagnosed health conditions, alopecia areata, ankylosing spondylitis, asthma, atopic dermatitis eczema, beta thalassemia, bipolar disorder, breast cancer, celiac disease, cervical cancer, chronic inflammatory demyelinating polyneuropathy, chronic kidney diseases, chronic obstructive pulmonary disease, colon cancer, colorectal cancer, crohn's disease, cystic fibrosis, depression, diabetes mellitus, duchenne muscular dystrophy, endometriosis, epilepsy, facioscapulohumeral muscular dystrophy, g6pd deficiency, general anxiety disorder, hepatitis b, hereditary hemorrhagic telangiectasia, hiv/aids, human papilloma virus, huntington's disease, idiopathic thrombocytopenic purpura, insomnia, kidney cancer, leukemia, lung cancer, lupus nephritis, lymphoma, melanoma, multiple myeloma, multiple sclerosis, myositis, myotonic dystrophy, ovarian cancer, pancreatic cancer, parkinson's disease, polycystic kidney diseases, prostate cancer, psoriasis, psoriatic arthritis, rosacea, scleroderma, sickle cell anemia, sickle cell trait, sjogren's syndrome, skin cancer, spinal muscular atrophy, systemic lupus erythematosus, thrombotic thrombocytopenic purpura, trisomy 21, ulcerative colitis